Nozha International Hospital Sae

Nozha International Hospital SAE exhibits a strong liquidity position, with a current ratio of 5.69 and cash and equivalents amounting to EGP 113.6 million, indicating robust short-term financial flexibility. The company's debt-to-equity ratio is 0.0, reflecting a conservative capital structure with no long-term debt obligations. This liquidity profile supports operational resilience and capacity for reinvestment. Profitability metrics are strong, with a return on equity (ROE) of 24.29% and a return on assets (ROA) of 21.29%, both exceeding the typical thresholds for healthcare facilities and services. These figures suggest efficient asset utilization and strong earnings relative to equity. The company's operating income of EGP 136.87 million and net income of EGP 174.19 million further underscore its profitability. The company's revenue is concentrated in Egypt, with no disclosed international operations or segment breakdowns. This geographic concentration may expose the company to local economic and regulatory risks, though the absence of segment data limits a more detailed assessment. Growth trajectory is supported by a positive free cash flow of EGP 121.24 million and capital expenditures of EGP -32.94 million, indicating reinvestment in operations. While no explicit growth targets are provided, the company's financial flexibility and profitability suggest capacity for expansion. Risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected. The absence of long-term debt and strong cash reserves mitigate financial distress risk. However, the lack of disclosed dilution sources or recent equity issuance activity limits visibility on potential equity dilution pressures. Recent filings and transcripts are not provided in the input data, so no specific events can be cited. The company's financial health and operational performance are primarily derived from the latest financial snapshot, with no additional qualitative disclosures available for analysis.